Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics

Objective: To observe the effect of Danhong injection (DHI) on perioperative metabolomics of unstable angina pectoris (UA) with blood stasis syndrome. Materials and Methods: A prospective, randomized, controlled, and single-blind clinical trial was conducted. Sixty-one UA patients with traditional C...

Full description

Bibliographic Details
Main Authors: Qian Niu, Wen-Long Xing, Yu-Tong Wang, Yan Zhu, Hong-Xu Liu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:World Journal of Traditional Chinese Medicine
Subjects:
Online Access:http://www.wjtcm.net/article.asp?issn=2311-8571;year=2022;volume=8;issue=2;spage=247;epage=256;aulast=Niu
_version_ 1818479114415243264
author Qian Niu
Wen-Long Xing
Yu-Tong Wang
Yan Zhu
Hong-Xu Liu
author_facet Qian Niu
Wen-Long Xing
Yu-Tong Wang
Yan Zhu
Hong-Xu Liu
author_sort Qian Niu
collection DOAJ
description Objective: To observe the effect of Danhong injection (DHI) on perioperative metabolomics of unstable angina pectoris (UA) with blood stasis syndrome. Materials and Methods: A prospective, randomized, controlled, and single-blind clinical trial was conducted. Sixty-one UA patients with traditional Chinese medicine blood stasis syndrome undergoing elective percutaneous coronary intervention (PCI) were randomly divided into the Danhong and control groups, and 10 healthy volunteers were included as baseline. The Danhong group received western medicine + DHI treatment, while the control group received western medicine + saline. Nontargeted metabolomics was used to analyze the serum metabolites of healthy volunteers in the Danhong and control groups before and 5 days after PCI. Results: Before treatment, there was no significant difference in serum metabolites between the Danhong and control groups, but there was a significant difference between the two groups and the healthy group. Differential metabolites were clustered mainly in glycerophospholipid, sphingolipid, purine, and amino acid groups, which were generated in their metabolic pathways. After 5 days of PCI, the profiles of serum metabolites were significantly closer between the Danhong-or control-treated groups and that of the healthy group. Furthermore, DHI treatment converted the serum metabolite profile more to that of the healthy group than the control treatment. Conclusion: The beneficial effect of DHI on patients with unstable angina is reflected at the level of serum metabolic biomarkers.
first_indexed 2024-12-10T09:56:56Z
format Article
id doaj.art-6ab8e65e9b994a5b881314d0b04fcd1f
institution Directory Open Access Journal
issn 2311-8571
language English
last_indexed 2024-12-10T09:56:56Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series World Journal of Traditional Chinese Medicine
spelling doaj.art-6ab8e65e9b994a5b881314d0b04fcd1f2022-12-22T01:53:28ZengWolters Kluwer Medknow PublicationsWorld Journal of Traditional Chinese Medicine2311-85712022-01-018224725610.4103/wjtcm.wjtcm_63_21Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomicsQian NiuWen-Long XingYu-Tong WangYan ZhuHong-Xu LiuObjective: To observe the effect of Danhong injection (DHI) on perioperative metabolomics of unstable angina pectoris (UA) with blood stasis syndrome. Materials and Methods: A prospective, randomized, controlled, and single-blind clinical trial was conducted. Sixty-one UA patients with traditional Chinese medicine blood stasis syndrome undergoing elective percutaneous coronary intervention (PCI) were randomly divided into the Danhong and control groups, and 10 healthy volunteers were included as baseline. The Danhong group received western medicine + DHI treatment, while the control group received western medicine + saline. Nontargeted metabolomics was used to analyze the serum metabolites of healthy volunteers in the Danhong and control groups before and 5 days after PCI. Results: Before treatment, there was no significant difference in serum metabolites between the Danhong and control groups, but there was a significant difference between the two groups and the healthy group. Differential metabolites were clustered mainly in glycerophospholipid, sphingolipid, purine, and amino acid groups, which were generated in their metabolic pathways. After 5 days of PCI, the profiles of serum metabolites were significantly closer between the Danhong-or control-treated groups and that of the healthy group. Furthermore, DHI treatment converted the serum metabolite profile more to that of the healthy group than the control treatment. Conclusion: The beneficial effect of DHI on patients with unstable angina is reflected at the level of serum metabolic biomarkers.http://www.wjtcm.net/article.asp?issn=2311-8571;year=2022;volume=8;issue=2;spage=247;epage=256;aulast=Niudanhong injectionmetabolomicsperioperative percutaneous coronary interventionunstable angina pectoris
spellingShingle Qian Niu
Wen-Long Xing
Yu-Tong Wang
Yan Zhu
Hong-Xu Liu
Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
World Journal of Traditional Chinese Medicine
danhong injection
metabolomics
perioperative percutaneous coronary intervention
unstable angina pectoris
title Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
title_full Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
title_fullStr Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
title_full_unstemmed Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
title_short Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
title_sort danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
topic danhong injection
metabolomics
perioperative percutaneous coronary intervention
unstable angina pectoris
url http://www.wjtcm.net/article.asp?issn=2311-8571;year=2022;volume=8;issue=2;spage=247;epage=256;aulast=Niu
work_keys_str_mv AT qianniu danhonginjectionimproveselectivepercutaneouscoronaryinterventioninuapatientswithbloodstasissyndromerevealedbyperioperativemetabolomics
AT wenlongxing danhonginjectionimproveselectivepercutaneouscoronaryinterventioninuapatientswithbloodstasissyndromerevealedbyperioperativemetabolomics
AT yutongwang danhonginjectionimproveselectivepercutaneouscoronaryinterventioninuapatientswithbloodstasissyndromerevealedbyperioperativemetabolomics
AT yanzhu danhonginjectionimproveselectivepercutaneouscoronaryinterventioninuapatientswithbloodstasissyndromerevealedbyperioperativemetabolomics
AT hongxuliu danhonginjectionimproveselectivepercutaneouscoronaryinterventioninuapatientswithbloodstasissyndromerevealedbyperioperativemetabolomics